302-19: Gabapentin Use & Misuse

4.71 (14 votes)

302-19:  Gabapentin Use & Misuse

Consider Gabapentin in the light of current practice, to understand it’s use and misuse. Consider the implications of gabapentin misuse for clinical practice and future research.

Presenter:  Christian J. Teter, PharmD, BCPP, RPh

Disclosures: The speaker has indicated a significant financial interest or other affiliation with Marblehead NeuroPsychiatric Rx, LLC. Off-label uses will be discussed during this presentation. The activity planners have no conflicts of interest to disclose.

Session Length:  1 hour 20 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

  1. Identify the scope (e.g., prevalence, risk factors, motives, outcomes) of gabapentin misuse.
  2. Describe the implications of gabapentin misuse for clinical practice and future research.

Keywords:  Psychopharmacology, Drug Diversion, Gabapentin

Continuing Nursing Education:
1.25 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
17th Annual Clinical Psychopharmacology Institute
Louisville, KY
Sunday, June 9, 2019
9:45am - 11:15am

The contact hours for this session expire:  June 30, 2021

Components visible upon registration.